Detalles de la búsqueda
1.
Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis.
Hepatology
; 77(6): 2052-2062, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36811400
2.
Alcohol-related liver disease phenotype impacts survival after an acute variceal bleeding episode.
Liver Int
; 43(7): 1548-1557, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37183551
3.
Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology.
Liver Int
; 42(8): 1783-1792, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35643936
4.
Non-pharmacologic direct cost of a simplified strategy with glecaprevir/pibrentasvir for 8 weeks in naïve non-cirrhotic patients with hepatitis C implemented in clinical practice. The Just SIMPLE Study.
Gastroenterol Hepatol
; 45(5): 342-349, 2022 May.
Artículo
en Inglés, Español
| MEDLINE | ID: mdl-34129903
5.
Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis.
J Hepatol
; 75(3): 589-599, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33905794
6.
ß blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial.
Lancet
; 393(10181): 1597-1608, 2019 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30910320
7.
Efficacy and Pharmacokinetics of Glecaprevir and Pibrentasvir With Concurrent Use of Acid-Reducing Agents in Patients With Chronic HCV Infection.
Clin Gastroenterol Hepatol
; 17(3): 527-535.e6, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30012435
8.
Effectiveness and safety of elbasvir/grazoprevir therapy in patients with chronic HCV infection: Results from the Spanish HEPA-C real-world cohort.
J Viral Hepat
; 26(1): 55-64, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30265418
9.
Eight weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV genotype 1b with mild-moderate fibrosis: Results from a real-world cohort.
Liver Int
; 39(1): 90-97, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30160363
10.
Impact of sustained viral response in the evolution of minimal hepatic encephalopathy: A prospective pilot study.
Ann Hepatol
; 18(3): 429-433, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31054981
11.
Impact of Sustained Viral Response in the Evolution of Minimal Hepatic Encephalopathy: a Prospective Pilot Study.
Ann Hepatol
; 18(1): 203-208, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31362817
12.
Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis C.
J Hepatol
; 66(4): 718-723, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28039098
13.
Development of hyperdynamic circulation and response to ß-blockers in compensated cirrhosis with portal hypertension.
Hepatology
; 63(1): 197-206, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26422126
14.
High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4.
Liver Int
; 37(12): 1823-1832, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28481460
15.
Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma.
Dig Dis Sci
; 62(3): 784-793, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28078526
16.
Grazoprevir, Elbasvir, and Ribavirin for Chronic Hepatitis C Virus Genotype 1 Infection After Failure of Pegylated Interferon and Ribavirin With an Earlier-Generation Protease Inhibitor: Final 24-Week Results From C-SALVAGE.
Clin Infect Dis
; 62(1): 32-6, 2016 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26371152
17.
Altered Underlying Renal Tubular Function in Patients With Chronic Hepatitis B Receiving Nucleos(t)ide Analogs in a Real-World Setting: The MENTE Study.
J Clin Gastroenterol
; 50(9): 779-89, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27332746
18.
Grazoprevir and elbasvir plus ribavirin for chronic HCV genotype-1 infection after failure of combination therapy containing a direct-acting antiviral agent.
J Hepatol
; 63(3): 564-72, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25895428
19.
Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysis.
Liver Int
; 35(1): 90-100, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25113158
20.
Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high- or low-risk stigmata.
Scand J Gastroenterol
; 49(10): 1181-90, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25144754